- IN₹36.17bn
- IN₹41.70bn
- IN₹25.65bn
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees
Brief: Aarti Drugs Commences Commercialization Of Manufacturing Plant Located At Sayakha
Aarti Drugs gains on strong Q1 profit growth
India's Aarti Drugs eyes best day in 21-months after Q4 profit jump
Brief: Aarti Drugs March-Quarter Consol Net Profit 628.6 Mln Rupees
Brief: Aarti Drugs Receives Administrative Warning Letter From SEBI
Brief: Aarti Drugs Says SEBI Issues Administrative Warning To Co's Compliance Officer, Company Secretary
India's Aarti Drugs surges as U.S. FDA lifts import restrictions
Brief: Aarti Drugs To Acquire 26.25% Equity In Pro-ZEAL Green Power Nine
Brief: Aarti Drugs Approves 250 Million Rupees Investment In Subsidiary
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 370.5 Million Rupees
India's Aarti Drugs falls after lower Q2 profit
India's Aarti Drugs up after getting GMP certification
Brief: Aarti Drugs Says Receipt Of GMP Certificate From UK-MHRA For Manufacturing Facility Of Unit
India's Shivalik Rasayan climbs on US FDA approval for facility
India's Aarti Drugs falls as US FDA issues inspectional observations